购物车
- 全部删除
- 您的购物车当前为空
Anti-EGFR Antibody-PE (5D853) 是一种 PE-conjugated Mouse 抗体,靶向 EGFR。Anti-EGFR Antibody-PE (5D853) 可用于 FCM。
Anti-EGFR Antibody-PE (5D853) 是一种 PE-conjugated Mouse 抗体,靶向 EGFR。Anti-EGFR Antibody-PE (5D853) 可用于 FCM。
产品描述 | Anti-EGFR Antibody-PE (5D853) is a PE-conjugated Mouse antibody targeting EGFR. Anti-EGFR Antibody-PE (5D853) can be used in FCM. |
Ig Type | Monoclonal Mouse IgG1 |
克隆号 | 5D853 |
交叉反应 | Human |
验证活性 | Flow cytometric analysis of EGFR expression on human A431 cells. |
应用 | FCM |
推荐剂量 | 2 μl/Test, 0.1 mg/ml |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This product is a recombinant monoclonal antibody expressed from HEK293 cells. Then conjugated with PE under optimum conditions, the unreacted PE was removed. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
研究背景 | As a member of the epidermal growth factor receptor (EGFR) family, EGFR protein is type I transmembrane glycoprotein that binds a subset of EGF family ligands including EGF, amphiregulin, TGF-α, betacellulin, etc. EGFR protein plays a crucial role in signaling pathway in the regulation of cell proliferation, survival and differentiation. Binding of a ligand induces EGFR protein homo- or heterodimerization, the subsequent tyrosine autophosphorylation and initiates various down stream pathways (MAPK, PI3K/PKB and STAT). In addition, EGFR signaling also has been shown to exert action on carcinogenesis and disease progression, and thus EGFR protein is proposed as a target for cancer therapy currently.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | PE |
其他可选修饰符 | Unconjugated/APC/FITC/Biotin |
可提供抗体种类 | 5 |
免疫原 | Recombinant Human EGFR / HER1 / ErbB1 protein (TMPY-00742) |
抗原种属 | Human |
研究领域 | Cancer Drug Targets, Receptor Tyrosine Kinases (RTKs) |
储存方式 | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
运输方式 | Shipping with blue ice. |
评论内容